Liabilities / Assets
81st percentile
Higher debt load relative to assets than 81% of similar nonprofits.
Association for Accessible Medicines
990 • Fiscal year 2017 • EIN 52-2252820
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.53x
Liabilities / Revenue
39th percentile
Higher debt load relative to revenue than 39% of similar nonprofits.
Net Margin
9th percentile
Higher net margin than 9% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
36th percentile
Faster asset growth than 36% of similar nonprofits.
Revenue Growth
92nd percentile
Faster revenue growth than 92% of similar nonprofits.
Balance Sheet
Assets
Up$11,655,437
Up $421,877 (+3.8%) from 2016
Net Assets
Down$5,455,511
Down $2,677,296 (-33%) from 2016
Liabilities
Up$6,199,926
Up $3,099,173 (+100%) from 2016
Revenue And Expenses
Revenue
Up$24,822,702
Up $7,259,735 (+41%) from 2016
Expenses
Up$27,499,998
Up $8,249,058 (+43%) from 2016
Net Income
Down-$2,677,296
Down $989,323 (-59%) from 2016
Historical Trend
Filing Detail Status
This 2017 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Jump To
Filing Snapshot
- Filing Period
- Jan 1, 2017 to Dec 31, 2017
Mission and Program Overview
Mission
The organization fosters and promotes the interests of the generic pharmaceutical and biosimilar industry.
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2017 • Form 990Summary only. Only limited summary data is available for this year.
- Assets
- $11,655,437
- Liabilities
- $6,199,926
- Net assets
- $5,455,511
- Revenue
- $24,822,702
- Expenses
- $27,499,998
- Net income
- -$2,677,296